Trial site
Strasbourg
- 10running trials
- 10closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Multiple sclerosis4 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Asthma1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Epilepsy1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Melanoma1 trial
- Myeloproliferative neoplasms1 trial
- and 3 more
- Phase
- Phase 39 trials
- Phase 27 trials
- Phase 1/21 trial
- Status
- Completed9 trials
- Active, not recruiting6 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Completed
Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Completed
Terminated
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026